EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Axonics's enterprise value is $3,081.5 Mil.
Axonics's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $366.4 Mil. Therefore, Axonics's EV-to-Revenue for today is 8.41.
The historical rank and industry rank for Axonics's EV-to-Revenue or its related term are showing as below:
AXNX'
s EV-to-Revenue Range Over the Past 10 Years
Min: 6.1 Med: 17.16 Max: 1998.34
Current: 8.41
During the past 8 years, the highest EV-to-Revenue of Axonics was 1998.34. The lowest was 6.10. And the median was 17.16.
AXNX's EV-to-Revenue is ranked worse than 78.79% of 825
companies
in the Medical Devices & Instruments industry
Industry Median: 3.07
vs AXNX: 8.41
As of today (2024-04-25), Axonics's stock price is $66.54.
Axonics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $7.46. Therefore, Axonics's PS Ratio for today is 8.92.
Axonics EV-to-Revenue Historical Data
The historical data trend for Axonics's EV-to-Revenue can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Axonics's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Axonics's EV-to-Revenue Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Axonics's EV-to-Revenue distribution charts can be found below:
* The bar in red indicates where Axonics's EV-to-Revenue falls into.
Axonics's current Enterprise Value is $3,081.5 Mil.
Axonics's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $366.4 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Axonics's share price for today is $66.54.
Axonics's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $7.46.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Axonics EV-to-Revenue Related Terms
Thank you for viewing the detailed overview of Axonics's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.
Axonics Inc is a United States-based medical technology company. It focuses on developing and commercializing novel products for adults with bladder and bowel dysfunction, that include implantable SNM systems to treat urinary urge incontinence and urinary urgency frequency (UUF); a urethral bulking agent (Bulkamid) to treat female stress urinary incontinence. SNM therapy is primarily used to treat patients with overactive bladder, fecal incontinence, and urinary retention.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
AXNX has been successfully added to your 